Be A Freedom Fighter · Bill Library
HR 10706 — Strengthening Innovation in Medicare and Medicaid Act
Freedom score: +4 (scale −10 to +10)
- Individual rights: 0
- Property rights: 0
- Economic freedom: +1
- Privacy & due process: +2
- Government power: +1
Sponsor: Rep. Smith, Adrian [R-NE-3] · Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (2026-10-01)
Full text on GovInfo (introduced version) · Congress.gov · ← Bill Library index
Findings — 14 highlighted provisions
Each item below is one provision documented in the findings file. The same provision is highlighted in the full text underneath, with its section citation and criterion. Everything else on this page is plain, unreviewed bill text.
- Sec. 3(a)–(d) · Individual Rights — Phase-I model size/duration limitations and safety/beneficiary monitoring can lessen involuntary changes to patient treatment, but do not themselves guarantee particular treatment or create a new general bodily-autonomy right See in text ↓
- Sec. 3(a)–(b) · Economic Freedom — Caps Phase-I Medicare/Medicaid Innovation model testing at five years and the lesser of 10% of applicable individuals or 500,000 beneficiaries; beginning FY2027 no more than six new Phase-I models per year and no more than five concurrent involuntary/compulsory models See in text ↓
- Sec. 3(c) · Economic Freedom — Secretary must set up provider/supplier applications for hardship waivers due to economic hardship or loss of care access within 60 days; granting relief still requires Secretary determination See in text ↓
- Sec. 4(a)–(b) · Economic Freedom — For proposed new, expanded or modified models Secretary must send designated committees a report; model proceeds absent congressional joint resolution of disapproval within 45 days; fast-track internal House/Senate rules are specified for such resolutions See in text ↓
- Sec. 8(a)–(b) · Economic Freedom — Repeals part of the statutory prohibition on duplicative Medicare accountable-care-program participation; CMI must take nearby already-running models into account; must report on overlapping payment arrangements See in text ↓
- Sec. 9(a)–(c) · Economic Freedom — Expands permissible CMI quality-focused models to include models designed for patient safety and improved outcomes and specified hospital care bundles, including indirect long-term savings; this also expands federal model-choice discretion See in text ↓
- Sec. 3(d) · Privacy and Due Process — Requires continuous real-time monitoring of effects on beneficiaries and mitigation of adverse impacts; text does not authorize collecting a new specific category of beneficiary personal data, but monitoring mechanisms are unspecified See in text ↓
- Sec. 5 · Privacy and Due Process — Requires public notice with evaluation/selection criteria and at least 45 days for comment, plus consultation of clinicians, providers and other stakeholders See in text ↓
- Sec. 6(a)–(b) · Privacy and Due Process — Modifies judicial-review restrictions by inserting exceptions for enforcement of laws/constitutional protections and deleting specified bars; exact scope depends on underlying Social Security Act §1115A(d)(2) See in text ↓
- Sec. 9(d) · Privacy and Due Process — Requires provision to model participants of CMS Chief Actuary assumptions/data supporting certification or non-certification, including in proposed termination, modification and expansion rules See in text ↓
- Sec. 4(a) · Government Power — Model proposals proceed by default unless joint disapproval resolution is passed within 45 days. The bill also rewrites privilege, referral, discharge, debate and veto-time rules for that resolution; these are congressional procedure, not direct private enforcement See in text ↓
- Sec. 7, Sec. 8(b), Sec. 10 · Government Power — Annualizes certain CMI reports from 2027, requires December 15 filing, overlap assessment within 60 days, and GAO workforce/authority report within 12 months See in text ↓
- Sec. 9(e) · Government Power — Changes outcome-based model evaluation and participant care-quality measures See in text ↓
- Sec. 4(b), Sec. 6(b), Sec. 11 · Government Power — Default applicability for testing/expansion/modification is January 1, 2027 except earlier dates specified in individual provisions; Secs. 4 and 6 operate at enactment See in text ↓
Full text (introduced version)
47 of 61 text blocks highlighted. Source: GovInfo, fetched cached.
SECTION 1. SHORT TITLE.
SEC. 2. SENSE OF CONGRESS.
SEC. 3. DEFINING CMI MODEL TESTING PARAMETERS.
Sec. 3(a)–(d) · Individual Rights — Phase-I model size/duration limitations and safety/beneficiary monitoring can lessen involuntary changes to patient treatment, but do not themselves guarantee particular treatment or create a new general bodily-autonomy right
Sec. 3(a)–(b) · Economic Freedom — Caps Phase-I Medicare/Medicaid Innovation model testing at five years and the lesser of 10% of applicable individuals or 500,000 beneficiaries; beginning FY2027 no more than six new Phase-I models per year and no more than five concurrent involuntary/compulsory models
Sec. 3(a)–(d) · Individual Rights — Phase-I model size/duration limitations and safety/beneficiary monitoring can lessen involuntary changes to patient treatment, but do not themselves guarantee particular treatment or create a new general bodily-autonomy right
Sec. 3(a)–(b) · Economic Freedom — Caps Phase-I Medicare/Medicaid Innovation model testing at five years and the lesser of 10% of applicable individuals or 500,000 beneficiaries; beginning FY2027 no more than six new Phase-I models per year and no more than five concurrent involuntary/compulsory models
Sec. 3(a)–(d) · Individual Rights — Phase-I model size/duration limitations and safety/beneficiary monitoring can lessen involuntary changes to patient treatment, but do not themselves guarantee particular treatment or create a new general bodily-autonomy right
Sec. 3(c) · Economic Freedom — Secretary must set up provider/supplier applications for hardship waivers due to economic hardship or loss of care access within 60 days; granting relief still requires Secretary determination
Sec. 3(a)–(d) · Individual Rights — Phase-I model size/duration limitations and safety/beneficiary monitoring can lessen involuntary changes to patient treatment, but do not themselves guarantee particular treatment or create a new general bodily-autonomy right
Sec. 3(d) · Privacy and Due Process — Requires continuous real-time monitoring of effects on beneficiaries and mitigation of adverse impacts; text does not authorize collecting a new specific category of beneficiary personal data, but monitoring mechanisms are unspecified
SEC. 4. IMPLEMENTATION OF TESTING AND EXPANSION OF MODELS WITH CONGRESSIONAL INACTION.
Sec. 4(a)–(b) · Economic Freedom — For proposed new, expanded or modified models Secretary must send designated committees a report; model proceeds absent congressional joint resolution of disapproval within 45 days; fast-track internal House/Senate rules are specified for such resolutions
Sec. 4(a) · Government Power — Model proposals proceed by default unless joint disapproval resolution is passed within 45 days. The bill also rewrites privilege, referral, discharge, debate and veto-time rules for that resolution; these are congressional procedure, not direct private enforcement
Sec. 4(a)–(b) · Economic Freedom — For proposed new, expanded or modified models Secretary must send designated committees a report; model proceeds absent congressional joint resolution of disapproval within 45 days; fast-track internal House/Senate rules are specified for such resolutions
Sec. 4(b), Sec. 6(b), Sec. 11 · Government Power — Default applicability for testing/expansion/modification is January 1, 2027 except earlier dates specified in individual provisions; Secs. 4 and 6 operate at enactment
SEC. 5. PUBLIC INPUT.
Sec. 5 · Privacy and Due Process — Requires public notice with evaluation/selection criteria and at least 45 days for comment, plus consultation of clinicians, providers and other stakeholders
Sec. 5 · Privacy and Due Process — Requires public notice with evaluation/selection criteria and at least 45 days for comment, plus consultation of clinicians, providers and other stakeholders
Sec. 5 · Privacy and Due Process — Requires public notice with evaluation/selection criteria and at least 45 days for comment, plus consultation of clinicians, providers and other stakeholders
Sec. 5 · Privacy and Due Process — Requires public notice with evaluation/selection criteria and at least 45 days for comment, plus consultation of clinicians, providers and other stakeholders
Sec. 5 · Privacy and Due Process — Requires public notice with evaluation/selection criteria and at least 45 days for comment, plus consultation of clinicians, providers and other stakeholders
Sec. 5 · Privacy and Due Process — Requires public notice with evaluation/selection criteria and at least 45 days for comment, plus consultation of clinicians, providers and other stakeholders
Sec. 5 · Privacy and Due Process — Requires public notice with evaluation/selection criteria and at least 45 days for comment, plus consultation of clinicians, providers and other stakeholders
SEC. 6. REESTABLISHING JUDICIAL REVIEW.
Sec. 6(a)–(b) · Privacy and Due Process — Modifies judicial-review restrictions by inserting exceptions for enforcement of laws/constitutional protections and deleting specified bars; exact scope depends on underlying Social Security Act §1115A(d)(2)
Sec. 6(a)–(b) · Privacy and Due Process — Modifies judicial-review restrictions by inserting exceptions for enforcement of laws/constitutional protections and deleting specified bars; exact scope depends on underlying Social Security Act §1115A(d)(2)
Sec. 6(a)–(b) · Privacy and Due Process — Modifies judicial-review restrictions by inserting exceptions for enforcement of laws/constitutional protections and deleting specified bars; exact scope depends on underlying Social Security Act §1115A(d)(2)
Sec. 6(a)–(b) · Privacy and Due Process — Modifies judicial-review restrictions by inserting exceptions for enforcement of laws/constitutional protections and deleting specified bars; exact scope depends on underlying Social Security Act §1115A(d)(2)
Sec. 6(a)–(b) · Privacy and Due Process — Modifies judicial-review restrictions by inserting exceptions for enforcement of laws/constitutional protections and deleting specified bars; exact scope depends on underlying Social Security Act §1115A(d)(2)
Sec. 6(a)–(b) · Privacy and Due Process — Modifies judicial-review restrictions by inserting exceptions for enforcement of laws/constitutional protections and deleting specified bars; exact scope depends on underlying Social Security Act §1115A(d)(2)
Sec. 6(a)–(b) · Privacy and Due Process — Modifies judicial-review restrictions by inserting exceptions for enforcement of laws/constitutional protections and deleting specified bars; exact scope depends on underlying Social Security Act §1115A(d)(2)
Sec. 6(a)–(b) · Privacy and Due Process — Modifies judicial-review restrictions by inserting exceptions for enforcement of laws/constitutional protections and deleting specified bars; exact scope depends on underlying Social Security Act §1115A(d)(2)
Sec. 4(b), Sec. 6(b), Sec. 11 · Government Power — Default applicability for testing/expansion/modification is January 1, 2027 except earlier dates specified in individual provisions; Secs. 4 and 6 operate at enactment
SEC. 7. REVISION OF REPORTING REQUIREMENT.
Sec. 7, Sec. 8(b), Sec. 10 · Government Power — Annualizes certain CMI reports from 2027, requires December 15 filing, overlap assessment within 60 days, and GAO workforce/authority report within 12 months
Sec. 7, Sec. 8(b), Sec. 10 · Government Power — Annualizes certain CMI reports from 2027, requires December 15 filing, overlap assessment within 60 days, and GAO workforce/authority report within 12 months
Sec. 7, Sec. 8(b), Sec. 10 · Government Power — Annualizes certain CMI reports from 2027, requires December 15 filing, overlap assessment within 60 days, and GAO workforce/authority report within 12 months
SEC. 8. ADDRESSING OVERLAP IN VALUE-BASED CARE PROGRAMS.
Sec. 8(a)–(b) · Economic Freedom — Repeals part of the statutory prohibition on duplicative Medicare accountable-care-program participation; CMI must take nearby already-running models into account; must report on overlapping payment arrangements
Sec. 8(a)–(b) · Economic Freedom — Repeals part of the statutory prohibition on duplicative Medicare accountable-care-program participation; CMI must take nearby already-running models into account; must report on overlapping payment arrangements
Sec. 8(a)–(b) · Economic Freedom — Repeals part of the statutory prohibition on duplicative Medicare accountable-care-program participation; CMI must take nearby already-running models into account; must report on overlapping payment arrangements
Sec. 8(a)–(b) · Economic Freedom — Repeals part of the statutory prohibition on duplicative Medicare accountable-care-program participation; CMI must take nearby already-running models into account; must report on overlapping payment arrangements
Sec. 7, Sec. 8(b), Sec. 10 · Government Power — Annualizes certain CMI reports from 2027, requires December 15 filing, overlap assessment within 60 days, and GAO workforce/authority report within 12 months
Sec. 8(a)–(b) · Economic Freedom — Repeals part of the statutory prohibition on duplicative Medicare accountable-care-program participation; CMI must take nearby already-running models into account; must report on overlapping payment arrangements
Sec. 7, Sec. 8(b), Sec. 10 · Government Power — Annualizes certain CMI reports from 2027, requires December 15 filing, overlap assessment within 60 days, and GAO workforce/authority report within 12 months
Sec. 8(a)–(b) · Economic Freedom — Repeals part of the statutory prohibition on duplicative Medicare accountable-care-program participation; CMI must take nearby already-running models into account; must report on overlapping payment arrangements
Sec. 7, Sec. 8(b), Sec. 10 · Government Power — Annualizes certain CMI reports from 2027, requires December 15 filing, overlap assessment within 60 days, and GAO workforce/authority report within 12 months
Sec. 8(a)–(b) · Economic Freedom — Repeals part of the statutory prohibition on duplicative Medicare accountable-care-program participation; CMI must take nearby already-running models into account; must report on overlapping payment arrangements
Sec. 7, Sec. 8(b), Sec. 10 · Government Power — Annualizes certain CMI reports from 2027, requires December 15 filing, overlap assessment within 60 days, and GAO workforce/authority report within 12 months
SEC. 9. MODEL ELIGIBILITY AND QUALITY OF CARE.
Sec. 9(a)–(c) · Economic Freedom — Expands permissible CMI quality-focused models to include models designed for patient safety and improved outcomes and specified hospital care bundles, including indirect long-term savings; this also expands federal model-choice discretion
Sec. 9(a)–(c) · Economic Freedom — Expands permissible CMI quality-focused models to include models designed for patient safety and improved outcomes and specified hospital care bundles, including indirect long-term savings; this also expands federal model-choice discretion
Sec. 9(a)–(c) · Economic Freedom — Expands permissible CMI quality-focused models to include models designed for patient safety and improved outcomes and specified hospital care bundles, including indirect long-term savings; this also expands federal model-choice discretion
Sec. 9(a)–(c) · Economic Freedom — Expands permissible CMI quality-focused models to include models designed for patient safety and improved outcomes and specified hospital care bundles, including indirect long-term savings; this also expands federal model-choice discretion
Sec. 9(a)–(c) · Economic Freedom — Expands permissible CMI quality-focused models to include models designed for patient safety and improved outcomes and specified hospital care bundles, including indirect long-term savings; this also expands federal model-choice discretion
Sec. 9(d) · Privacy and Due Process — Requires provision to model participants of CMS Chief Actuary assumptions/data supporting certification or non-certification, including in proposed termination, modification and expansion rules
Sec. 9(d) · Privacy and Due Process — Requires provision to model participants of CMS Chief Actuary assumptions/data supporting certification or non-certification, including in proposed termination, modification and expansion rules
Sec. 9(d) · Privacy and Due Process — Requires provision to model participants of CMS Chief Actuary assumptions/data supporting certification or non-certification, including in proposed termination, modification and expansion rules
Sec. 9(e) · Government Power — Changes outcome-based model evaluation and participant care-quality measures
Sec. 9(e) · Government Power — Changes outcome-based model evaluation and participant care-quality measures
Sec. 9(e) · Government Power — Changes outcome-based model evaluation and participant care-quality measures
SEC. 10. GAO REPORT.
Sec. 7, Sec. 8(b), Sec. 10 · Government Power — Annualizes certain CMI reports from 2027, requires December 15 filing, overlap assessment within 60 days, and GAO workforce/authority report within 12 months
Sec. 7, Sec. 8(b), Sec. 10 · Government Power — Annualizes certain CMI reports from 2027, requires December 15 filing, overlap assessment within 60 days, and GAO workforce/authority report within 12 months
Sec. 7, Sec. 8(b), Sec. 10 · Government Power — Annualizes certain CMI reports from 2027, requires December 15 filing, overlap assessment within 60 days, and GAO workforce/authority report within 12 months
Sec. 7, Sec. 8(b), Sec. 10 · Government Power — Annualizes certain CMI reports from 2027, requires December 15 filing, overlap assessment within 60 days, and GAO workforce/authority report within 12 months
SEC. 11. EFFECTIVE DATE.
Sec. 4(b), Sec. 6(b), Sec. 11 · Government Power — Default applicability for testing/expansion/modification is January 1, 2027 except earlier dates specified in individual provisions; Secs. 4 and 6 operate at enactment
Findings source: bill-scores-v2-batch50-findings-2026-11-15.md. Highlights come only from that file; no finding, score, or provision was invented for this page.
What you can do
Contact your U.S. Representative and Senators about this bill.
Find your Representative Contact your Senators
Spot an error on this page? Report it.